Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials

Total article views   Abstract views HTML views PDF downloads Totals
5,160 Dovepress* 4,578 304+ 686 4,882
PubMed Central* 0 278 103 278
Totals 4,578 582 789 5,160
*Since 4 May 2018
+Since July 2016

View citations on PubMed Central and Google Scholar